Kubtec Introduces TomoView Patent-pending Tomosynthesis Technology for Breast Cancer Specimen Radiography

Kubtec, a leader in innovation for digital specimen radiography, announced  its development of TomoView, a groundbreaking tomosynthesis technology for digital specimen radiography of excised breast tissue. The company’s patent-pending technology allows for multi-planar x-ray imaging for thorough margin analysis of excised breast tissue and is the core foundation on which Kubtec’s upcoming system release, MOZART, is based.

By employing Kubtec’s advanced TomoView technology, MOZART will offer a comprehensive solution for imaging excised breast tissue while increasing accuracy, saving time, and reducing re-excision rates in the operating room.

“The TomoView technology in MOZART allows for comprehensive intraoperative margin analysis in a single step, without turning and repositioning the specimen container multiple times to obtain additional views,” said Kubtec’s Director of Research and Development, Chester Lowe, Ph.D., FACR. “Using TomoView’s multi-dimensional imaging technology, and requiring no repositioning of specimens, the MOZART system will provide a faster, more efficient specimen radiography solution for radiology, surgery, and pathology department.”

“TomoView technology represents a quantum leap forward in superior intraoperative specimen radiography,” said Vikram Butani, president of Kubtec. “The system offers radiologists, surgeons and pathologists an elegant synthesis of digital technologies for the most advanced specimen imaging available.”

Kubtec’s announcement coincides with the American Society of Breast Surgeons’ 15th Annual Meeting, held in Las Vegas in May. 

For more information: www.kubtec.com